兆馳股份(002429.SZ)2020年度淨利潤預增40%至60%
格隆匯 1 月 25日丨兆馳股份(002429.SZ)公佈,預計2020年度歸屬於上市公司股東的淨利潤158861.54萬元至181556.05萬元,同比增長40%至60%;扣除非經常性損益後的淨利潤154899.04萬元至182234.16萬元,同比增長70%至100%。
2020年,公司積極準備疫情防控期間的復工復產工作,大力開拓國內外市場,加大產品推廣力度,訂單數量同比上升,總體經營情況良好。秉持着“精細化管理”的運營理念,公司通過合理比配計劃採購與集中採購份額,進一步完善原材料採購策略,實現降本增效,產品毛利率得到提升,故實現歸屬於上市公司股東的淨利潤同比增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.